| Blue silver: a very sensitive colloidal Coomassie G‐250 staining for proteome analysis G Candiano, M Bruschi, L Musante, L Santucci, GM Ghiggeri, ... Electrophoresis 25 (9), 1327-1333, 2004 | 2509 | 2004 |
| Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ... The Journal of experimental medicine 198 (4), 557-567, 2003 | 1084 | 2003 |
| Design and use of a phage display library: human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel A Pini, F Viti, A Santucci, B Carnemolla, L Zardi, P Neri, D Neri Journal of Biological Chemistry 273 (34), 21769-21776, 1998 | 631 | 1998 |
| Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. L Zardi, B Carnemolla, A Siri, TE Petersen, G Paolella, G Sebastio, ... The EMBO journal 6 (8), 2337-2342, 1987 | 443 | 1987 |
| Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin L Borsi, E Balza, M Bestagno, P Castellani, B Carnemolla, A Biro, ... International journal of cancer 102 (1), 75-85, 2002 | 427 | 2002 |
| A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. B Carnemolla, E Balza, A Siri, L Zardi, MR Nicotra, A Bigotti, PG Natali The Journal of cell biology 108 (3), 1139-1148, 1989 | 421 | 1989 |
| Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform D Neri, B Carnemolla, A Nissim, A Leprini, G Querzè, E Balza, A Pini, ... Nature biotechnology 15 (12), 1271-1275, 1997 | 400 | 1997 |
| Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix B Carnemolla, L Borsi, E Balza, P Castellani, R Meazza, A Berndt, ... Blood, The Journal of the American Society of Hematology 99 (5), 1659-1665, 2002 | 362 | 2002 |
| Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis R Castriconi, A Dondero, R Augugliaro, C Cantoni, B Carnemolla, ... Proceedings of the National Academy of Sciences 101 (34), 12640-12645, 2004 | 342 | 2004 |
| Selective targeted delivery of TNFα to tumor blood vessels L Borsi, E Balza, B Carnemolla, F Sassi, P Castellani, A Berndt, ... Blood 102 (13), 4384-4392, 2003 | 312 | 2003 |
| Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis PK Naik, PD Bozyk, JK Bentley, AP Popova, CM Birch, CA Wilke, CD Fry, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 303 …, 2012 | 294 | 2012 |
| Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. L Borsi, B Carnemolla, P Castellani, C Rosellini, D Vecchio, G Allemanni, ... The Journal of cell biology 104 (3), 595-600, 1987 | 243 | 1987 |
| Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies A Siri, B Carnemolla, M Saginati, A Leprini, G Casari, F Baralle, L Zardi Nucleic acids research 19 (3), 525-531, 1991 | 240 | 1991 |
| Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues L Borsi, B Carnemolla, G Nicolò, B Spina, G Tanara, L Zardi International journal of cancer 52 (5), 688-692, 1992 | 231 | 1992 |
| Phage antibodies with pan‐species recognition of the oncofoetal angiogenesis marker fibronectin ED‐B domain B Carnemolla, D Neri, P Castellani, A Leprini, G Neri, A Pini, G Winter, ... International journal of cancer 68 (3), 397-405, 1996 | 201 | 1996 |
| PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis D Pende, C Bottino, R Castriconi, C Cantoni, S Marcenaro, P Rivera, ... Molecular immunology 42 (4), 463-469, 2005 | 195 | 2005 |
| Differentiation between high-and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin P Castellani, L Borsi, B Carnemolla, A Biro, A Dorcaratto, GL Viale, D Neri, ... The American journal of pathology 161 (5), 1695-1700, 2002 | 177 | 2002 |
| Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody B Carnemolla, P Castellani, M Ponassi, L Borsi, S Urbini, G Nicolo, ... The American journal of pathology 154 (5), 1345-1352, 1999 | 171 | 1999 |
| The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. B Carnemolla, A Leprini, G Allemanni, M Saginati, L Zardi Journal of Biological Chemistry 267 (34), 24689-24692, 1992 | 163 | 1992 |
| Anti-cancer therapies employing IL-2 cytokine tumor targeting: contribution of innate, adaptive and immunosuppressive cells in the anti-tumor efficacy L Mortara, E Balza, A Bruno, A Poggi, P Orecchia, B Carnemolla Frontiers in Immunology 9, 2905, 2018 | 128 | 2018 |
